65377-86-8 Usage
General Description
(3beta,5Z,7E,10alpha,22E)-9,10-Secoergosta-5,7,22-trien-3-ol, also known as Ergosterol, is a sterol compound found in fungi and yeast. It is a precursor of vitamin D2 and is important for the synthesis of cell membranes. Ergosterol has been studied for its potential health benefits, including its anti-inflammatory and antioxidant properties, as well as its role in promoting bone health. Additionally, it has been investigated for its potential use as a therapeutic agent for conditions such as cancer and infectious diseases. Ergosterol is commonly used as a supplement in the form of vitamin D2 to support overall health and wellness.
Check Digit Verification of cas no
The CAS Registry Mumber 65377-86-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,3,7 and 7 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 65377-86:
(7*6)+(6*5)+(5*3)+(4*7)+(3*7)+(2*8)+(1*6)=158
158 % 10 = 8
So 65377-86-8 is a valid CAS Registry Number.
65377-86-8Relevant articles and documents
Hydrotitanation-Protonation of Vitamin D2 and Its Analogues: An Efficient Method for the Preparation of 10,19-Dihydrovitamins D2 Including Dihydrotachysterol2
Cota, J. G.,Meilan, M. C.,Mourino, A.,Castedo, L.
, p. 6094 - 6099 (2007/10/02)
In this study we describe an easy and efficient method for the preparation of the known 10,19-dihydrovitamins D2 2b (DHV2-II), 2c (DHV2-IV), 3c (dihydrotachysterol2, DHT2), and the new dihydrovitamins D2 2f and 2g.This method is based on the regioselective hydrometalation reaction of vitamin D2 and its derivatives with the system Cp2TiCl2-LiAlH4 or Cp2TiCl2-Red-Al (Aldrich).Under optimal conditions, the reaction with the former of these hydrometalating systems takes place with a high degree of stereoselectivity and allows labelling at C-19.
Photochemical transformations. Part 34. Structures of the toxisterols.
Barrett,Barton,Russell,Widdowson
, p. 631 - 643 (2007/10/06)
-